Diego Ferone

17.0k total citations · 3 hit papers
310 papers, 10.8k citations indexed

About

Diego Ferone is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Neurology. According to data from OpenAlex, Diego Ferone has authored 310 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 210 papers in Endocrinology, Diabetes and Metabolism, 127 papers in Epidemiology and 74 papers in Neurology. Recurrent topics in Diego Ferone's work include Pituitary Gland Disorders and Treatments (173 papers), Neuroendocrine Tumor Research Advances (123 papers) and Growth Hormone and Insulin-like Growth Factors (118 papers). Diego Ferone is often cited by papers focused on Pituitary Gland Disorders and Treatments (173 papers), Neuroendocrine Tumor Research Advances (123 papers) and Growth Hormone and Insulin-like Growth Factors (118 papers). Diego Ferone collaborates with scholars based in Italy, Netherlands and United States. Diego Ferone's co-authors include Gaetano Lombardi, Paolo Marzullo, Annamaria Colao, Annamaria Colao, Francesco Minuto, Rosario Pivonello, Bartolomeo Merola, Leo J. Hofland, Federico Gatto and Gaetana Cerbone and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Diego Ferone

296 papers receiving 10.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management

2004 944 citations Annamaria Colao, Diego Ferone et al. profile →
ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms

2016 330 citations Diego Ferone, Wouter W. de Herder et al. Neuroendocrinology profile →
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study

2024 113 citations Sten Myrehaug, Beth Chasen et al. profile →

Peers

Countries citing papers authored by Diego Ferone

Since Specialization

Citations

This map shows the geographic impact of Diego Ferone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Ferone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Ferone more than expected).

Fields of papers citing papers by Diego Ferone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego Ferone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Ferone. The network helps show where Diego Ferone may publish in the future.

Co-authorship network of co-authors of Diego Ferone

This figure shows the co-authorship network connecting the top 25 collaborators of Diego Ferone. A scholar is included among the top collaborators of Diego Ferone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diego Ferone. Diego Ferone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	“Who and how to screen for endogenous hypercortisolism among young women presenting with clinical hyperandrogenism and/or menstrual abnormalities ” 2025 ·Journal of Endocrinological Investigation ·Francesco Ferraù, (unknown), (unknown), (unknown), Diego Ferone, Emanuela Arvat	1
2	Erectile and Sexual Function Determinants in Men with Type 1 Diabetes 2025 ·Diabetology ·(unknown), (unknown), (unknown), (unknown), Maria Grazia Calevo, Davide Maggi, Diego Ferone, Nicola Minuto, Marta Bassi	1
3	7376 Efficacy and Safety of CAM2029 in Patients With Controlled or Inadequately Controlled Acromegaly on Standard-of-Care Treatment: Interim Data for the “New to CAM2029” Patient Subgroup in a Phase 3 Study (ACROINNOVA 2) 2024 ·Journal of the Endocrine Society ·Diego Ferone, Joanna L. Spencer-Segal, Güzin Fidan Yaylalı, Mirjana Doknić, (unknown), Alexander Dreval, Aleksandra Gilis‐Januszewska, (unknown), Irina Bancos, Laurence Katznelson, (unknown), (unknown), Alberto M Pedroncelli, Fredrik Tiberg	0
4	211MO First-line efficacy of [177Lu]Lu-DOTA-TATE in patients with advanced grade 2 and grade 3, well-differentiated gastroenteropancreatic neuroendocrine tumors by tumor grade and primary origin: Subgroup analysis of the phase III NETTER-2 study 2024 ·Annals of Oncology ·(unknown), Daniel M. Halperin, Sten Myrehaug, (unknown), (unknown), Pamela L. Kunz, Beth Chasen, (unknown), (unknown), D-Y. Oh, Changhoon Yoo, Stephen Falk, (unknown), (unknown), Ying Zhang, (unknown), Diego Ferone	4
5	Challenging diagnosis of resistance to thyroid hormone in a patient with COVID-19, pituitary microadenoma and unusual response to octreotide long-acting release test 2024 ·Endocrinology Diabetes and Metabolism Case Reports ·(unknown), (unknown), Stefano Gay, (unknown), Irene Campi, Luca Persani, (unknown), Diego Ferone, Federico Gatto	0
6	Impact of Vitamin D Deficiency on Tumor Aggressiveness in Neuroendocrine Neoplasms 2023 ·Nutrients ·Manuela Albertelli, (unknown), (unknown), (unknown), Mara Boschetti, Giorgio Luciano, Davide Campana, Stefano Gay, (unknown), Diego Ferone, Lara Vera	4
7	Prevalence of Lactose Intolerance in Patients with Hashimoto Thyroiditis and Impact on LT4 Replacement Dose 2022 ·Nutrients ·Elisa Marabotto, Diego Ferone, (unknown), Lara Vera, (unknown), Edoardo Savarino, Giorgia Bodini, Manuele Furnari, Patrizia Zentilin, Vincenzo Savarino, Massimo Giusti, (unknown), Marcello Bagnasco, Manuela Albertelli, Edoardo G. Giannini	2
8	Octreotide and Pasireotide Combination Treatment in Somatotroph Tumor Cells: Predominant Role of SST2 in Mediating Ligand Effects 2021 ·Cancers ·(unknown), Federica Barbieri, Marica Arvigo, (unknown), Adriana Bajetto, (unknown), (unknown), (unknown), (unknown), (unknown), Gianluigi Zona, Diego Ferone, Tullio Florio, Federico Gatto	7
9	Octreotide-Resistant Acromegaly: Challenges and Solutions 2020 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), (unknown), Mara Boschetti, Gianluigi Zona, (unknown), Diego Ferone, Federico Gatto	1
10	Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms 2019 ·International Journal of Molecular Sciences ·Federico Gatto, Federica Barbieri, Marica Arvigo, Stefano Thellung, (unknown), Manuela Albertelli, Diego Ferone, Tullio Florio	35
11	ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors 2017 ·Neuroendocrinology ·Gregory Kaltsas, Martyn Caplin, Philippa Davies, Diego Ferone, Rocio García‐Carbonero, Simona Grozinsky‐Glasberg, Dieter Hörsch, Eva Tiensuu Janson, Réza Kianmanesh, Beata Kos‐Kudła, Marianne Pavel, Anja Rinke, Massimo Falconi, Wouter W. de Herder, (unknown)	99
12	Patient-derived xenograft in zebrafish embryos: a new platform for translational research in neuroendocrine tumors 2016 ·Endocrine ·Germano Gaudenzi, Manuela Albertelli, Alessandra Dicitore, Roberto Würth, Federico Gatto, Federica Barbieri, Franco Cotelli, Tullio Florio, Diego Ferone, Luca Persani, Giovanni Vitale	84
13	Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas 2016 ·Molecular Neurobiology ·Roberto Würth, Federica Barbieri, Alessandra Pattarozzi, Germano Gaudenzi, Federico Gatto, Pietro Fiaschi, (unknown), Gianluigi Zona, Antonio Daga, Luca Persani, Diego Ferone, Giovanni Vitale, Tullio Florio	48
14	Clinical outcome and evidence of high rate post-surgical anterior hypopituitarism in a cohort of TSH-secreting adenoma patients: Might somatostatin analogs have a role as first-line therapy? 2014 ·Pituitary ·Federico Gatto, Ludovica F. S. Grasso, Elena Nazzari, Thomas Cuny, Pasquale Anania, Carolina Di Somma, Annamaria Colao, Gianluigi Zona, G. Weryha, Rosario Pivonello, Diego Ferone	32
15	First in vitro study of human gastroenteropancreatic-neuroendocrine tumors: comparative effect of octreotide and pasireotide 2012 ·15th International & 14th European Congress of Endocrinology ·Amira Mohamed, Marie‐Pierre Blanchard, Manuela Albertelli, Patricia Niccoli, G. Monges, Sergio de Frutos, Vincent Moutardier, Jean‐Robert Delpéro, A Enjalbert, Tullio Florio, Diego Ferone, Alexandru Saveanu, Anne Barlier	1
16	Overexpression of Stromal Cell–Derived Factor 1 and Its Receptor CXCR4 Induces Autocrine/Paracrine Cell Proliferation in Human Pituitary Adenomas 2008 ·Clinical Cancer Research ·Federica Barbieri, Adriana Bajetto, Ralf Stumm, Alessandra Pattarozzi, Carola Porcile, Gianluigi Zona, Alessandra Dorcaratto, (unknown), Francesco Minuto, Renato Spaziante, Gennaro Schettini, Diego Ferone, Tullio Florio	88
17	In Vitro Characterization of Somatostatin Receptors in the Human Thymus and Effects of Somatostatin and Octreotide on Cultured Thymic Epithelial Cells 1999 ·Endocrinology ·Diego Ferone	25
18	Correlation of Scintigraphic Results Using¹²³I-Methoxybenzamide with Hormone Levels and Tumor Size Response to Quinagolide in Patients with Pituitary Adenomas 1998 ·The Journal of Clinical Endocrinology & Metabolism ·Diego Ferone, Secondo Lastoria, Annamaria Colao, P. Varrella, Gaetana Cerbone, Wanda Acampa, Bartolomeo Merola, Marco Salvatore, Gaetano Lombardi	34
19	Correlation of Scintigraphic Results Using 123I-Methoxybenzamide with Hormone Levels and Tumor Size Response to Quinagolide in Patients with Pituitary Adenomas 1998 ·The Journal of Clinical Endocrinology & Metabolism ·Diego Ferone	10
20	Prolactinomas Resistant to Standard Dopamine Agonists Respond to Chronic Cabergoline Treatment 1997 ·The Journal of Clinical Endocrinology & Metabolism ·Annamaria Colao, Antonella Di Sarno, Francesca Sarnacchiaro, Diego Ferone, Gianfranco Di Renzo, Bartolomeo Merola, Lucio Annunziato, Gaetano Lombardi	190

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact